Access cutting-edge acute leukemia treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access acute leukemia specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related acute leukemia treatment provided free
The purpose of this study is to assess Tacrolimus/Methotrexate/Ruxolitinib versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation
Sponsor: Incyte Corporation
Check if you qualify for this acute leukemia clinical trial in San Francisco, CA
If you're searching for acute leukemia treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.